- Report
- October 2024
- 183 Pages
Global
From €3244EUR$3,545USD£2,819GBP
€3605EUR$3,939USD£3,132GBP
- Report
- April 2025
- 200 Pages
Global
From €4109EUR$4,490USD£3,570GBP
- Report
- February 2025
- 200 Pages
Global
From €4109EUR$4,490USD£3,570GBP
- Report
- August 2022
- 118 Pages
Global
From €4118EUR$4,500USD£3,578GBP
- Report
- February 2024
- 97 Pages
Global
From €3500EUR$4,097USD£3,147GBP
- Report
- April 2025
- 50 Pages
Global
From €2425EUR$2,650USD£2,107GBP
- Report
- April 2025
- 50 Pages
Global
From €2425EUR$2,650USD£2,107GBP
- Report
- April 2025
- 50 Pages
Global
From €2425EUR$2,650USD£2,107GBP
Docusate is a laxative drug used to treat constipation and other gastrointestinal issues. It is a surfactant, meaning it helps to reduce the surface tension of stool, allowing it to pass more easily through the intestines. Docusate is available in both oral and rectal forms, and is often used in combination with other medications to treat constipation. It is also used to treat fecal impaction, a condition in which stool becomes hardened and difficult to pass.
Docusate is a widely used drug in the gastrointestinal market, and is available in both generic and brand name forms. It is often used in combination with other medications to treat constipation, and is available in both over-the-counter and prescription forms. It is also used to treat fecal impaction, a condition in which stool becomes hardened and difficult to pass.
Some companies in the Docusate market include GlaxoSmithKline, Pfizer, Merck, and Bayer. Show Less Read more